This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? However, in a tightly regulated industry like pharmaceuticals, every message, medium, and model must adhere to strict legal and ethical standards.
Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers. but not in the EU.
Pharmacompanies around the world have also faced similar threats , some of which have impacted national security and public health. Right now, it’s compliance by checkbox, in a static way. Pharmaceutical companies that are publicly traded will need to pay attention,” warns Kim.
The key lies in personalization, strategic segmentation, and strict adherence to industry regulations. This guide explores the best strategies for boosting engagement while ensuring compliance , helping pharma brands connect with their audiences more effectively. How can pharmacompanies improve email open rates?
SUMMARY: Pharmacompanies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties. Ethical leadership!
The boom in digital tech over COVID means that pharma can move faster than ever – but the industry’s traditional processes for asset approval are still holding timelines back. David Reily examines how pharmacompanies are responding to the increased burden of asset approval with new ways of working. Bhupinder McJennett, AbbVie.
Regulatory restrictions, privacy laws, and strict compliance rules make it one of the most challenging industries to navigate digitally. So, how can pharmacompanies leverage digital advertising strategies to maximize reach while staying compliant ? Heres how to maximize your reach and compliance.
M&A is an integral part of the lifecycle of pharmacompanies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. But what steps can the smaller companies at the cutting edge take to make them acquisition-ready and maximise their value during this process?
In October, Antares Pharma licensed Ferring Pharmaceuticals’ Nocdurna® (desmopressin acetate) sublingual tablet , which was approved in 2018 for the same indication as Noctiva and has a boxed warning highlighting the same risks. Manager of Regulatory Compliance. In 2019, Foundation Medicine and Bayer Healthcare Pharmaceuticals, Inc.
In terms of business transformation of the pharma industry, the areas that can see the most immediate effects are: (1) automated data compliance, (2) data sharing, and (3) data monetisation. Automated compliance. Challenges. New generation DS solutions, using multi-CDN technology, have overcome this issue. Conclusion.
That means maintaining regulatory readiness – because having cGMP compliance problems with the FDA can significantly exacerbate the problem. Until the company is found to be in compliance, there will not be a normal distribution of drug products. You can check out part 1 of this series, on maintaining GMP readiness, here.
Companies outsource to gain access to specialized expertise and technology, scale pharmacovigilance (PV) activities, and reduce costs. However, the efficiency and effectiveness of externalized safety activities are below expectations for many biotech and pharmacompanies.
Ensure Regulatory Compliance Navigating regulations can feel daunting, but its crucial. Regulatory compliance, understanding audience needs, and standing out in a crowded market are the most significant challenges. Why is digital marketing crucial for pharmacompanies?
For pharma marketers, these platforms provide an efficient way to reach doctors, caregivers, and patients while complying with strict regulations. Why Pharma Marketers Need Programmatic Advertising 1. Unlike consumer brands, pharmacompanies must: Avoid false or misleading claims about drug effectiveness.
The move to online international meetings has left pharmacompanies with uncertainty around contact compliance. To say the world of work has changed is something of an understatement in the pharma and biopharma industry. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity.
With millions of healthcare professionals (HCPs) and patients active on platforms like LinkedIn, Twitter, Facebook, and Instagram, pharma brands can no longer afford to stay silent. Effective social media strategies allow pharmacompanies to: Build trust with HCPs and patients. Short video clips with expert insights.
The global pandemic has caused pharmacompanies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. Will we go back to that?
In it, the authors report even lower levels of FDAAA compliance – a mere 20% of randomized clinical trials met requirements of posting results on clinicaltrials.gov within one year. Everyone I work with in pharma trials is painfully aware of the regulatory environment they work in.
However, balancing effective targeting, regulatory compliance, and patient trust can be a challenge. The key is precision, personalization, and compliance. Data-Driven Personalization : Using real-time insights, pharmacompanies can deliver tailored content to physicians and patients.
However, balancing effective targeting, regulatory compliance, and patient trust can be a challenge. The key is precision, personalization, and compliance. Data-Driven Personalization : Using real-time insights, pharmacompanies can deliver tailored content to physicians and patients.
With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. Imagine AI as a crystal ballit doesnt just reflect whats happening now but predicts the future of pharma marketing.
Even two years after the introduction of the General Data Protection Regulation (GDPR), the Information Commissioner Office is still fining companies who fail to fully protect their data. There are two sides of the data protection issue facing the pharma industry. What Does Ensuring Compliance Mean for Pharma?
Designed to explain either the risk management plan (RMP) or clinical trial results (CTR) in a way that a child can understand, lay summaries are now a required document for all clinical trials in the European Union (EU) following changes to EU Clinical Trials Regulations (EU-CTR) regulations earlier this year.
Some of the ways that Pharmacompanies have been using video to bridge the gap in the service of the Rep/HCP conversation include: HCP Peer-to-Peer Thought Leadership. We’ve also seen the video platform used by medical device, pharmacompanies, and KOLs to: Share best practices and launch new sales methodologies.
Pharmacompanies, healthcare providers and governments share a well-established common purpose: the desire to make disease a thing of the past. I saw a statistic in a Health Europe article, published in September this year, which reported that 81% of patients do not feel listened to by pharmacompanies.
As consumers become increasingly digital-savvy, pharmacompanies need to revolutionize their approach. With new platforms and evolving regulations, it can feel overwhelming. Leveraging Social Media Social media is a goldmine for pharmacompanies, but it requires careful strategy.
For pharma marketing executives , reaching audiences in meaningful, personalized ways has never been more critical. But with complex regulations, fast-evolving digital tools, and the challenges of building trust, it’s tough to know where to start. By focusing on trust and compliance, pharmacompanies can overcome these hurdles.
Benefits of VR & AR in Pharma Advertising VR and AR offer a unique opportunity for pharmacompanies to engage with customers in a more immersive and interactive way. For example, by using VR and AR, a pharmacompany could create an interactive 3D environment that allows customers to explore the product in detail.
It’s been made possible by an all-hands-on-deck approach from the NHS, academia, regulators and other players in the health system who have worked together to produce clinical data on vaccines and therapies for COVID-19. It is really important and we have seen a lot of pharmacompanies interested in the UK.
From digital transformation and personalized marketing to compliance and competition, the upcoming years will demand flexibility and innovative thinking. So, what will be the top challenges in 2025, and how can pharma marketers tackle them? Scaling personalized marketing while ensuring regulatory compliance is no small feat.
Marketing pharma has become a complex and competitive field, with companies vying for the attention of healthcare providers (HCPs), patients, and regulators alike. Understanding the Challenges in Marketing Pharma Marketing pharma isn’t without its challenges. The good news?
With increasing competition and stricter complianceregulations, pharma marketing teams must adopt data-driven and personalized marketing strategies to capture the attention of HCPs. But how can pharma brands stand out in a crowded market?
The biggest gathering of pharmacompanies in Europe right now on the commercial side, the Veeva Systems Summit permits the sharing of best practices and of new ideas. Facts that they gleaned included: Across Europe, only 52% of HCPs will accept a visit from a pharmacompany (i.e. That, he said, is commercial excellence.
When capturing medical and field insights you have to comply with numerous regulations relevant to the world of data privacy – a challenge often compounded by the many different variables that govern the process of insight capture and analysis. What is your corporate compliance policy? Capturing Medical Insights With Zero-Risk.
Pharma marketing is unique due to its highly regulated environment, making it crucial for companies to balance promotional efforts with compliance. One of the primary objectives of pharma marketing is to communicate the benefits and safety profiles of medications to healthcare providers and patients.
With a competitive landscape and ever-evolving regulations, having effective pharmaceutical marketing strategies is crucial for pharmacompanies looking to stand out. Pharma marketers must think creatively and strategically. Warning: Always adhere to compliance guidelines when posting on social media.
For marketing executives, the challenge lies in balancing personalization with compliance. Navigating HIPAA regulations while tailoring messages requires careful planning and ethical decision-making. From updated FDA guidelines to stricter European regulations, keeping up with these changes is critical.
Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharmacompanies and end-users. As patients become more digitally savvy, pharmacompanies are investing in creating seamless digital experiences that cater to their needs and preferences.
Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. There is a huge opportunity for pharmacompanies to capitalise on by focusing on increased DEI in clinical trials.
So, how can pharma marketing executives make the most of this technology? An ad exchange is a digital marketplace where advertisers (like pharmacompanies) and publishers (websites or platforms) buy and sell ad space. Compliance Challenges and Solutions Pharma advertising faces strict regulations.
Companies need to start with a clear business plan/objective, get sponsorship from those in higher leadership roles, and involve the right stakeholders, such as the brand teams, MLR teams, and compliance as early as possible. Agile collaboration internally and externally.
To compete now, companies need to own a larger portion of the treatment journey and the overall patient care experience. Commercial leaders should leverage the internal capabilities and centres of excellence that pharmacompanies are increasingly building. About BrightInsight.
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharmacompanies’ customer communication methods require reimagining as technology progresses.
But how do you stand out in a crowded digital space while maintaining compliance and integrity? This article explores effective strategies to help pharma marketing executives navigate the digital landscape successfully. Social media allows your brand to communicate directly with followers in a regulated, friendly manner.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content